Literature DB >> 3873071

B-cell stimulatory factor 1 activates resting B cells.

E M Rabin, J Ohara, W E Paul.   

Abstract

B-cell stimulatory factor 1 (BSF-1) is a T-cell-derived lymphokine that acts together with low concentrations of anti-IgM antibodies to stimulate resting B cells to enter the G1 phase of the cell cycle and to synthesize DNA. We show here that supernatants from EL-4 cells, rich in BSF-1 activity, and BSF-1 purified by high-pressure liquid chromatography (HPLC-BSF-1) act on resting B cells, in the absence of anti-IgM antibodies, to prepare them to respond to anti-IgM and BSF-1. A 24-hour preculture with BSF-1 speeds the entry into S phase of B cells subsequently cultured with anti-IgM and BSF-1 by approximately equal to 12 hours and causes substantial increase in cell volume of all resting B cells. Both of these effects, stimulated either by EL-4 supernatants or by HPLC-BSF-1, are inhibited by a monoclonal anti-BSF-1 antibody. These results lead us to propose that BSF-1 should be regarded as a B-cell activation factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873071      PMCID: PMC397681          DOI: 10.1073/pnas.82.9.2935

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Nomenclature of lymphokines which regulate B-lymphocytes.

Authors:  W E Paul
Journal:  Mol Immunol       Date:  1984-04       Impact factor: 4.407

2.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium.

Authors:  D E Mosier
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

Review 4.  Regulation of B-cell growth and differentiation by soluble factors.

Authors:  M Howard; W E Paul
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody.

Authors:  J T Kung; S O Sharrow; D G Sieckmann; R Lieberman; W E Paul
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response.

Authors:  D G Sieckmann; R Asofsky; D E Mosier; I M Zitron; W E Paul
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

7.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Transient expression of interleukin 2 receptors. Consequences for T cell growth.

Authors:  D A Cantrell; K A Smith
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

9.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.

Authors:  H J Leibson; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  T-cell and mast cell lines respond to B-cell stimulatory factor 1.

Authors:  T R Mosmann; M W Bond; R L Coffman; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 3.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

4.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

5.  Activation of immunoglobulin control elements in transgenic mice.

Authors:  A E Miller; D L Ennist; K Ozato; H Westphal
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Phenotypic characterization of cytokine expression in patients with IgA nephropathy.

Authors:  N Yano; M Endoh; Y Nomoto; H Sakai; K Fadden; A Rifai
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

7.  Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.

Authors:  M Hatakeyama; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

8.  Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.

Authors:  J G Shields; R J Armitage; B N Jamieson; P C Beverley; R E Callard
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

9.  Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells.

Authors:  K K Christian-Ritter; L D Hill; E B Hoie; T L Zach
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

10.  A novel Lyn-protein kinase Cδ/ε-protein kinase D axis is activated in B cells by signalosome-independent alternate pathway BCR signaling.

Authors:  Benchang Guo; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2013-04-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.